Background: Endothelial injury is part of the pathogenesis of sepsis. The microRNA-126 (miR-126) was previously identified as an endothelial biomarker and is known to play a critical role in preserving endothelial cell integrity. However, the role of miRNA-126 in sepsis is unclear.
Method: Blood samples were collected from sepsis patients at the first Affiliated Hospital of Sun Yat-sen University within 24 h (n = 60) and on day 7 (n = 51) after diagnosis, and once from control subjects (n = 46). MiR-126-3p expression was evaluated by quantitative real-time PCR. The miR-126-3p level was correlated with clinical data and a set of routine and experimental biomarkers. The outcome of sepsis patients was determined by follow-up at 28 days after collection of blood samples on day 7.
Result: MiR-126-3p level was significantly downregulated in sepsis patients 24 h after diagnosis compared with control subjects. Degree of downregulation of serum miR-126-3p correlated with the severity of sepsis. To determine the diagnostic accuracy of miR-126-3p, the receiver operating characteristic (ROC) was performed and the AUC of miR-126-3p was 0.735. Furthermore, serum miR-126-3p concentration at this time point was correlated with the expression markers of systemic inflammation, bacterial infection, and renal and hepatic dysfunction. However, serum miR-126-3p level on day 7 day did not differ between surviving sepsis patients and those who died.
Conclusion: These results indicate that miR-126-3p could be a diagnostic biomarker for sepsis.
Keywords: Sepsis; diagnosis; endothelial injury; miR-126-3p; prognosis.
IJCEP Copyright © 2018.
Conflict of interest statement
Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From SepsisQ Hu et al. Front Immunol 9, 3099. PMID 30687316.Adult-onset Still's disease (AOSD) is a systemic inflammatory disease characterized by cytokine storm. However, a diagnostic test for AOSD in clinical use is yet to be va …
[Value of Serum miR-155-5p and miR-133a-3p Expression for the Diagnosis and Prognosis Evaluation of Sepsis]C Lan et al. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 28 (8), 694-8. PMID 27434558.The expression of serum miR-155-5p and miR-133a-3p may be used as specific indicators for the diagnosis of sepsis. And the expression of miR-155-5p can be used as indepen …
A Novel microRNA miR-1165-3p as a Potential Diagnostic Biomarker for Allergic AsthmaC Wu et al. Biomarkers 24 (1), 56-63. PMID 30015513.This study showed that serum miR-1165-3p can potentially be utilized as a noninvasive biomarker that is able to aid in the diagnosis and characterization of allergic asth …
Identification of Non-Invasive Biomarkers for Chronic Atrophic Gastritis From Serum Exosomal microRNAsH Liu et al. BMC Cancer 19 (1), 129. PMID 30736753.These results suggested that hsa-miR-122-5p in serum exosomes might serve as a potential biomarker for CAG diagnosis.
Serum Expression Levels of microRNA-382-3p, -598-3p, -1246 and -184 in Breast Cancer PatientsL Fu et al. Oncol Lett 12 (1), 269-274. PMID 27347136.The purpose of the present study was to investigate the serum levels of microRNA (miRNA/miR)-382-3p, -598-3p, -1246 and -184 in breast cancer patients and to assess their …